Article Text

Download PDFPDF
Imatinib-induced melanonychia in a patient of chronic myeloid leukaemia: rarely reported side effect

Statistics from


  • Contributors Contribution of the corresponding author is in designing the work, analysing and interpreting the data, drafting the work, finalising the version to be published and agreeing to be accountable for all aspect of the work. Contribution of coauthor is in designing the study, interpretation of data, drafting and revising the content and approving the final version to be submitted.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.